摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-methyl-4-(prop-2-enyl)quinoline | 38178-77-7

中文名称
——
中文别名
——
英文名称
2-methyl-4-(prop-2-enyl)quinoline
英文别名
4-allyl-2-methylquinoline;4-Allyl-2-methyl-chinolin;4-Allyl-2-methylchinolin;2-Methyl-4-prop-2-enylquinoline
2-methyl-4-(prop-2-enyl)quinoline化学式
CAS
38178-77-7
化学式
C13H13N
mdl
——
分子量
183.253
InChiKey
ITOYOHUQSQWBEO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    295.5±9.0 °C(Predicted)
  • 密度:
    1.032±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.7
  • 重原子数:
    14
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.15
  • 拓扑面积:
    12.9
  • 氢给体数:
    0
  • 氢受体数:
    1

反应信息

  • 作为反应物:
    描述:
    2-methyl-4-(prop-2-enyl)quinoline咪唑 、 selenium(IV) oxide 、 硼烷四氢呋喃络合物 作用下, 以 四氢呋喃1,4-二氧六环N,N-二甲基甲酰胺 为溶剂, 反应 5.0h, 生成
    参考文献:
    名称:
    Synthesis of Fluorine-Containing Phosphodiesterase 10A (PDE10A) Inhibitors and the In Vivo Evaluation of F-18 Labeled PDE10A PET Tracers in Rodent and Nonhuman Primate
    摘要:
    A series of fluorine-containing PDE10A inhibitors were designed and synthesized to improve the metabolic stability of [C-11]MP-10. Twenty of the 22 new analogues had high potency and selectivity for PDE10A: 18a-j, 19d-j, 20a-b, and 21b had IC50 values <5 nM for PDE10A. Seven F-18 labeled compounds [F-18](18)a-e, [F-18]18g, and [F-18]20a were radiosynthesized by F-18-introduction onto the quinoline rather than the pyrazole moiety of the MP-10 pharmacophore and performed in vivo evaluation. Biodistribution studies in rats showed similar to 2-fold higher activity in the PDE10A-enriched striatum than nontarget brain regions; this ratio increased from 5 to 30 min postinjection, particularly for [F-18]18a-d and [F-18]20a. Micro-PET studies of [F-18]18d and [F-18]20a in nonhuman primates provided clear visualization of striatum with suitable equilibrium kinetics and favorable metabolic stability. These results suggest this strategy may identify a F-18-labeled PET tracer for quantifying the levels of PDE10A in patients with CNS disorders including Huntington's disease and schizophrenia.
    DOI:
    10.1021/acs.jmedchem.5b01205
  • 作为产物:
    描述:
    4-羟基-2-甲基喹啉四(三苯基膦)钯N,N-二异丙基乙胺 、 lithium bromide 作用下, 以 四氢呋喃N,N-二甲基甲酰胺 为溶剂, 反应 24.67h, 生成 2-methyl-4-(prop-2-enyl)quinoline
    参考文献:
    名称:
    Synthesis of Fluorine-Containing Phosphodiesterase 10A (PDE10A) Inhibitors and the In Vivo Evaluation of F-18 Labeled PDE10A PET Tracers in Rodent and Nonhuman Primate
    摘要:
    A series of fluorine-containing PDE10A inhibitors were designed and synthesized to improve the metabolic stability of [C-11]MP-10. Twenty of the 22 new analogues had high potency and selectivity for PDE10A: 18a-j, 19d-j, 20a-b, and 21b had IC50 values <5 nM for PDE10A. Seven F-18 labeled compounds [F-18](18)a-e, [F-18]18g, and [F-18]20a were radiosynthesized by F-18-introduction onto the quinoline rather than the pyrazole moiety of the MP-10 pharmacophore and performed in vivo evaluation. Biodistribution studies in rats showed similar to 2-fold higher activity in the PDE10A-enriched striatum than nontarget brain regions; this ratio increased from 5 to 30 min postinjection, particularly for [F-18]18a-d and [F-18]20a. Micro-PET studies of [F-18]18d and [F-18]20a in nonhuman primates provided clear visualization of striatum with suitable equilibrium kinetics and favorable metabolic stability. These results suggest this strategy may identify a F-18-labeled PET tracer for quantifying the levels of PDE10A in patients with CNS disorders including Huntington's disease and schizophrenia.
    DOI:
    10.1021/acs.jmedchem.5b01205
点击查看最新优质反应信息

文献信息

  • Cobalt-Catalyzed Direct Electrochemical Cross-Coupling between Aryl or Heteroaryl Halides and Allylic Acetates or Carbonates
    作者:Paulo Gomes、Corinne Gosmini、Jacques Périchon
    DOI:10.1021/jo026421b
    日期:2003.2.1
    The electroreduction of a mixture of functionalized aromatic or heteroaromatic bromides or chlorides and allylic compounds such as acetates or carbonates in an electrochemical cell fitted with a sacrificial iron anode affords, in the presence of cobalt halide associated with pyridine as ligand in acetonitrile or DMF, the corresponding coupling product in good yields.
    在配有牺牲性铁阳极的电化学电池中,将功能化的芳族或杂芳族溴化物或氯化物与烯丙基化合物(如乙酸盐或碳酸盐)的混合物进行电还原,可在乙腈或DMF中与吡啶结合的卤化钴与配体结合时,得到相应的偶联产物,收率很高。
  • Synthesis of Fluorine-Containing Phosphodiesterase 10A (PDE10A) Inhibitors and the In Vivo Evaluation of F-18 Labeled PDE10A PET Tracers in Rodent and Nonhuman Primate
    作者:Junfeng Li、Xiang Zhang、Hongjun Jin、Jinda Fan、Hubert Flores、Joel S. Perlmutter、Zhude Tu
    DOI:10.1021/acs.jmedchem.5b01205
    日期:2015.11.12
    A series of fluorine-containing PDE10A inhibitors were designed and synthesized to improve the metabolic stability of [C-11]MP-10. Twenty of the 22 new analogues had high potency and selectivity for PDE10A: 18a-j, 19d-j, 20a-b, and 21b had IC50 values <5 nM for PDE10A. Seven F-18 labeled compounds [F-18](18)a-e, [F-18]18g, and [F-18]20a were radiosynthesized by F-18-introduction onto the quinoline rather than the pyrazole moiety of the MP-10 pharmacophore and performed in vivo evaluation. Biodistribution studies in rats showed similar to 2-fold higher activity in the PDE10A-enriched striatum than nontarget brain regions; this ratio increased from 5 to 30 min postinjection, particularly for [F-18]18a-d and [F-18]20a. Micro-PET studies of [F-18]18d and [F-18]20a in nonhuman primates provided clear visualization of striatum with suitable equilibrium kinetics and favorable metabolic stability. These results suggest this strategy may identify a F-18-labeled PET tracer for quantifying the levels of PDE10A in patients with CNS disorders including Huntington's disease and schizophrenia.
查看更多